GHK-Cu 2mg Capsules (60 Count) Research Compound
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) in oral capsule form provides a convenient research format for gastrointestinal and systemic research protocols examining copper peptide bioavailability and activity via oral routes. Each capsule contains 2mg of GHK-Cu — the naturally occurring tripeptide-copper complex first isolated from human plasma albumin by Loren Pickart in 1973. This 60-capsule vial provides research-grade GHK-Cu at ≥99% purity per capsule for extended oral administration research protocols.
Research Background
GHK-Cu is one of the most extensively characterized signaling peptides in human biology, modulating over 4,000 genes including upregulation of tissue repair, collagen synthesis, and antioxidant defense pathways, while downregulating inflammatory and cellular senescence-associated genes. Oral delivery research for GHK-Cu focuses on gut mucosal effects, systemic bioavailability studies, and gastrointestinal tissue repair applications — distinct from injectable and topical delivery routes. Published research has documented GHK-Cu’s anti-fibrotic effects in intestinal models, relevant to IBD and gut permeability research.
Compound Specifications
- Format: Oral capsules
- Purity: ≥99% per capsule (HPLC verified)
- Quantity: 60 capsules × 2mg GHK-Cu
- Storage: Cool, dry place, protected from light
- Molecular Formula: C₁₄H₂₄CuN₆O₄
- Molecular Weight: 403.9 Da
Certificate of Analysis
Third-party tested by independent ISO-certified laboratories. HPLC validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
